Related Experiment Video
Updated: Jun 23, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
TAVR vs. SAVR in Patients With Severe Aortic Stenosis and Chronic Kidney Disease Undergoing Dialysis: A Comprehensive
Maneeth Mylavarapu1,2, Madiha Kiyani3, Niharika Tanwar4
1Department of Cardiology, Endeavor Health Cardiovascular Institute, Endeavor Health Glenbrook Hospital, Glenview, Illinois, 60026, USA.
Insights
Transcatheter aortic valve replacement (TAVR) shows better early outcomes for dialysis patients with severe aortic stenosis (AS) compared to surgical aortic valve replacement (SAVR). TAVR reduces in-hospital mortality and length of stay, though pacemaker implantation is more frequent.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Management of severe aortic stenosis (AS) in patients with chronic kidney disease (CKD) on dialysis is complex.
- Both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) are options, but comparative outcomes are unclear in this high-risk group.
Purpose of the Study:
- To compare the postoperative clinical outcomes of TAVR versus SAVR in patients with severe AS and CKD undergoing dialysis.
Main Methods:
- A systematic review and meta-analysis adhering to PRISMA guidelines.
- Searched PubMed, EMBASE, Scopus, and Google Scholar for studies comparing TAVR and SAVR in severe AS patients with CKD on dialysis.
- Included ten retrospective studies with 28,625 patients (14,625 TAVR, 14,000 SAVR).
Main Results:
- TAVR was associated with significantly lower in-hospital mortality (OR 0.49; p=0.01) and shorter length of stay (LOS) (SMD -2.59; p≤0.04).
- The TAVR group had significantly higher odds of permanent pacemaker implantation (OR 2.25; p<0.00001).
Conclusions:
- TAVR demonstrates a favorable early safety profile in severe AS patients with CKD on dialysis.
- Lower in-hospital mortality and shorter LOS suggest improved early recovery with TAVR in this population.
Background:
Patients with chronic kidney disease (CKD) undergoing dialysis who also suffer from severe aortic stenosis (AS) present a complex management challenge. Both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) are treatment options, but comparative outcomes in this specific, high-risk population continue to remain unclear.
Aim:
This study aims to compare TAVR and SAVR postoperative clinical outcomes in patients with severe AS and CKD undergoing dialysis.
Methods:
According to PRISMA guidelines, a comprehensive search was conducted across various databases such as PubMed, EMBASE, Scopus, and Google Scholar. Original studies that compared the clinical outcomes between TAVR and SAVR in patients with severe AS and CKD undergoing dialysis were included in the study.
Results:
Ten studies, all retrospective, involving 28,625 (14,625 TAVR and 14,000 SAVR) patients with severe AS and CKD undergoing dialysis who underwent TAVR or SAVR were included in this study. Patients who underwent TAVR had significantly lower odds of in-hospital mortality (OR 0.49; 0.29, 0.84; p = 0.01) and shorter length of stay (LOS) (SMD -2.59; 95% CI -5.04, -0.14; p ≤ 0.04). However, the TAVR group had significantly higher odds of permanent pacemaker implantation (OR 2.25; 95% CI 1.71-2.94; p < 0.00001).
Conclusion:
In patients with severe AS and CKD undergoing dialysis, TAVR is associated with lower in-hospital mortality and shorter LOS, suggesting a favorable early safety profile and recovery in this population.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Hemodialysis I: Introduction
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
